Santhera Pharmaceuticals AG
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Santhera Pharmaceuticals AG
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives the majority of its revenue from the European Union.
/ 
Frequently asked questions
To buy Santhera Pharmaceuticals AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Santhera Pharmaceuticals AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Santhera Pharmaceuticals AG is SANN:xswx. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Santhera Pharmaceuticals AG has its primary listing on SIX Swiss Exchange. You can trade Santhera Pharmaceuticals AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Santhera Pharmaceuticals AG is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Santhera Pharmaceuticals AG as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Santhera Pharmaceuticals AG.